epoetin alfa or beta

DRUG3 trials

Sponsors

Hoffmann-La Roche

Conditions

Anemia

Phase 3

A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients

CompletedNCT00077610

Hoffmann-La RocheAnemia

Start: 2004-02-29End: 2005-08-31Updated: 2017-01-13

A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.

CompletedNCT00077623

Hoffmann-La RocheAnemia

Start: 2004-03-31End: 2005-09-30Updated: 2016-05-25

A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients

CompletedNCT00081484

Hoffmann-La RocheAnemia

Start: 2004-06-30End: 2006-03-31Updated: 2016-11-02

Related Papers

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).

2007-10-01108 citations